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Résumé en
anglais
AIM: To evaluate the implication of substitutions in the hepatitis C virus (HCV)
non-structural 5A (NS5A) protein in the resistance of HCV during mono-interferon
(IFN) or combined IFN-ribavirin (IFN-R) therapy. Although NS5A has been
reported to interact with the HCV RNA-dependent RNA polymerase, NS5B, as well
as with many cellular proteins, the function of NS5A in the life cycle of HCV
remains unclear.
METHODS: HCV quasispecies were studied by cloning and sequencing of
sequential isolates from patients infected by HCV genotype 1b. Patients were
treated by IFN-alpha2b for 3 mo followed by IFN-alpha2b alone or combined IFN-R
therapy for 9 additional months. Patients were categorized into two groups based
on their response to the treatments: 7 with sustained virological response (SVR)
(quasispecies = 150) and 3 non-responders (NR) to IFN-R (quasispecies = 106).
RESULTS: Prior to treatment, SVR patients displayed a lower complexity of
quasispecies than NR patients. Most patients had a decrease in the complexity of
quasispecies during therapy. Analysis of amino acids substitutions showed that the
degree of the complexity of the interferon sensitivity-determining region (ISDR)
and the V3 domain of NS5A protein was able to discriminate the two groups of
patients. Moreover, SVR patients displayed more variability in the NS5A region
than NR patients.
CONCLUSION: These results suggest that detailed molecular analysis of the
NS5A region may be important for understanding its function in IFN response
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